New publication of a large French clinical trial evaluating Ostenil Plus in osteoarthritis

200130-Ostenil-Plos-Publication-Website-Newsroom-1920x580
TRB-Chemedica-Forty-Years-Website-Slider-1920x580-1
200108-New-Logo-Website-Slider-1920x580
OUR HISTORYMANUFACTURING PLANTPARTNERSHIPS

OUR HISTORY

Read about the key events during our three decades of success

MANUFACTURING PLANT

Learn more about our Swiss production site

PARTNERSHIPS

Partnerships have been the key to our worldwide development, join our network

SWISS FIRM, GLOBAL NETWORK

Our strong network of 19 subsidiaries and distribution partners helps us to support patients and healthcare professionals in over 70 countries around the world.

See our locations

We care

From easing the discomfort of dry eye to aiding recovery following arthroscopy, through helping relieve pain and compromised function which results from tendinopathy or osteoarthritis,
everything we do is because we care.

Blue eye showing TRB Chemedica Ophthalmology area

OPHTHALMOLOGY

Learn More
Hand placed on a knee reprsenting the TRB Chemedica Rheumatology area

RHEUMATOLOGY

Learn More
Brain with a blue design showing TRB Chemedica neurology area

NEUROLOGY

Learn More

Our focus areas

We develop and manufacture highly effective pharmaceutical products, medical devices, and medical food supplements, all with excellent safety profiles.

HYALURONIC ACID DIACEREIN GM1 ganglioside

NEWSROOM

Catch up with the latest news, articles, events, and videos from TRB Chemedica International

With a constant growth since 1987, TRB Singapore evolved into an Asia-Pacific hub

LEARN MORE

The video of the conference “L’homme cérébral” that took place on March 13, 2021, is now online

Learn More

Publication of a clinical trial evaluating Ostenil Plus in osteoarthritis

Learn More